Cerecor Inc.·4

Jun 11, 7:36 PM ET

Calias Pericles 4

4 · Cerecor Inc. · Filed Jun 11, 2019

Insider Transaction Report

Form 4
Period: 2019-06-10
Calias Pericles
Chief Scientific Officer
Transactions
  • Purchase

    Common Stock

    2019-06-10$2.85/sh+4,549$12,95349,549 total
Holdings
  • Stock Option (Right to Buy)

    Exercise: $4.26Exp: 2028-07-16Common Stock (80,000 underlying)
    80,000
  • Stock Option (Right to Buy)

    Exercise: $6.22Exp: 2029-04-01Common Stock (175,000 underlying)
    175,000
  • Stock Option (Right to Buy)

    Exercise: $4.98Exp: 2029-05-24Common Stock (25,000 underlying)
    25,000
Footnotes (3)
  • [F1]These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan.
  • [F2]One-fourth of the shares subject to the stock option will vest on July 16, 2019, and the remaining three-fourths of the shares subject to the stock option will vest in substantially equal monthly installments over the following 36 months, provided the Reporting Person is then still providing continuous service as an employee, director or consultant.
  • [F3]One-fourth of the shares subject to the stock option will vest on April 1, 2020, and the remaining three-fourths of the shares subject to the stock option will vest in equal monthly installments over the following 36 months.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT